Dopson Pharma (India) Limited - Company Profile

It is a financial services public limited company based in Mumbai, Maharashtra, India, established in 1982.
1982 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Dopson Pharma (India) Limited

Dopson Pharma (India) Limited, a active public limited company, was established on 19 March 1982 in Mumbai, Maharashtra, India. Engaging in brokerage & trading services within the financial services sector, it holds CIN: U99999MH1982PLC026712. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.00 Cr.

It upholds a compliant status. Its leadership includes Kuldeep Agrawal (Director), Anil Mangal (Additional Director), Chetan Vinod Palikar (Additional Director). Past directors included Govind Keshav Purbia, Kuldeep Agrawal, Tulsiram Kayal. It holds no open charges and ₹9.13 M settled loans. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at G5/701, Garden Crest Chs Ltd., West Avenue Santacruz West Mumbai, Mumbai, Maharashtra, 400054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999MH1982PLC026712

  • Registration Number

    026712

  • Incorporation Date

    19 March 1982

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹6.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 6.00 Cr
  • Company Age 43 Year, 10 Months
  • Last Filing with ROC 31 Mar 2018
  • Satisfied Charges ₹ 9.13 M
  • Revenue Growth **** %
  • Profit Growth **** -54416.71%
  • Ebitda **** -54416.71%
  • Net Worth -99.95%
  • Total Assets -99.95%
Company report

Dopson Pharma (India) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dopson Pharma (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dopson Pharma (India) Limited?
Current Directors
Name Designation Appointment Date Status
Kuldeep Agrawal Director 29 Jun 2011 Current
Anil Mangal Additional Director 20 Apr 2017 Current
Chetan Vinod Palikar Additional Director 20 Mar 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Mar 2019 Past
Pramod Abcsdd Director 10 Nov 2018 Past
Pramod Abcsdd Director 25 Mar 2019 Past
Pramod Abcsdd Additional Director 20 May 2017 Past
Pramod Abcsdd Additional Director 20 Mar 2020 Past
Pramod Abcsdd Director 30 Jun 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dopson Pharma (India).

Dopson Pharma (India) Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 54416.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.95%.

Dopson Pharma (India) revenue growth over time
Dopson Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -99.95%
*******
*******
*******
*******
Profit or Loss
*******
 -54416.71%
*******
*******
*******
*******
Net Worth
*******
 -99.95%
*******
*******
*******
*******
EBITDA
*******
 -54416.71%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dopson Pharma (India)?

In 2018, Dopson Pharma (India) had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹9,125,000.00

Charges Breakdown by Lending Institutions
  • Corporation Bank : 0.85 Cr
  • Canara Bank : 0.06 Cr
Latest Charge Details
Date Lender Amount Status
09 Mar 2000 Corporation Bank ₹8.50 M Satisfied
10 Mar 1986 Canara Bank ₹0.18 M Satisfied
10 Mar 1983 Canara Bank ₹0.30 M Satisfied
15 Oct 1982 Canara Bank ₹0.15 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Dopson Pharma (India)?

Unlock and access historical data on people associated with Dopson Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dopson Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dopson Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dopson Pharma (India)
Recent Activity within the Organization
  • Director Appointment

    Progress on Chetan Vinod Palikar was appointed as a Additional Director was appointed as a Additional Director on 20 Mar 2020 & has been associated with this company since 5 years 10 months . was documented.

  • Annual General Meeting

    The activity Dopson Pharma (India) Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Dopson Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Anil Mangal was appointed as a Additional Director was appointed as a Additional Director on 20 Apr 2017 & has been associated with this company since 8 years 9 months . was completed.

  • Director Appointment

    Progress on Kuldeep Agrawal was appointed as a Director was appointed as a Director on 29 Jun 2011 & has been associated with this company since 14 years 7 months . was documented.

  • Charges

    Progress on A charge registered on 09 Mar 2000 via Charge ID 90364399 with Corporation Bank was fully satisfied on 14 Oct 2005. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dopson Pharma (India) Limited?

The CIN of Dopson Pharma (India) Limited is U99999MH1982PLC026712.

Where is Dopson Pharma (India) Limited headquartered?

Dopson Pharma (India) Limited is headquartered at G5/701, Garden Crest Chs Ltd., West Avenue Santacruz West Mumbai, Mumbai, Maharashtra, 400054.

When was Dopson Pharma (India) Limited incorporated?

Dopson Pharma (India) Limited was incorporated on 19 March 1982.

Who are the current directors of Dopson Pharma (India) Limited?

The current directors of Dopson Pharma (India) Limited are

What is the primary industry of Dopson Pharma (India) Limited?

The primary industry of Dopson Pharma (India) Limited is Financial Services.

Is Dopson Pharma (India) Limited a listed company?

Dopson Pharma (India) Limited is unlisted.

What is the capital structure of Dopson Pharma (India) Limited?

The authorized capital of Dopson Pharma (India) Limited is ₹10.00 Cr, and the paid-up capital is ₹6.00 Cr.

What is the compliance status of Dopson Pharma (India) Limited?

The compliance status of Dopson Pharma (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available